Advanced search
Publication Cover
Clinical Ophthalmology Volume 15, 2021 - Issue
Submit an article Journal homepage
123
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Factors Influencing Response to Aflibercept in Diabetic Macular Oedema Patients in a Diverse North West London Population: A Real-World Study

Sing Yue Sim1 Department of Ophthalmology, The Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UKView further author information
,
Arevik Ghulakhszian2 Department of Ophthalmology, London North West University Healthcare NHS Trust, London, UKView further author information
,
Amal Minocha1 Department of Ophthalmology, The Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UKView further author information
,
Dhannie Ramcharan2 Department of Ophthalmology, London North West University Healthcare NHS Trust, London, UKView further author information
,
Soroush Nokhostin3 Department of Ophthalmology, Imperial College Healthcare NHS Trust, London, UKORCID Iconhttps://orcid.org/0000-0002-8495-0358View further author information
ORCID Icon,
Richard Cheong-Leen1 Department of Ophthalmology, The Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UKView further author information
,
Sheena George1 Department of Ophthalmology, The Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UKView further author information
,
Esther Posner3 Department of Ophthalmology, Imperial College Healthcare NHS Trust, London, UKView further author information
&
Christiana Dinah2 Department of Ophthalmology, London North West University Healthcare NHS Trust, London, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0815-4771View further author information
ORCID Icon show all
Pages 2089-2097 | Published online: 20 May 2021

References

  • Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–564.
  • Bahrami B, Zhu M, Hong T, Chang A. Diabetic macular oedema: pathophysiology, management challenges and treatment resistance. Diabetologia. 2016;59(8):1594–1608. doi:10.1007/s00125-016-3974-8
  • Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating Ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular oedema. Ophthalmology. 2010;117:1064–77.e35. doi:10.1016/j.ophtha.2010.02.031
  • Mitchell P, Chong V. Baseline predictors of 3-year responses to Ranibizumab and laser photocoagulation therapy in patients with visual impairment due to diabetic macular edema (DME): the RESTORE study. Invest Ophthalmol Vis Sci. 2013;54:2373. doi:10.1167/iovs.12-10757
  • Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of Ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter Phase II study. Diabetes Care. 2010;33:2399–2405. doi:10.2337/dc10-0493
  • Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the Ranibizumab for edema of the macula in diabetes (READ-2) study. Ophthalmology. 2010;117:2146–2151. doi:10.1016/j.ophtha.2010.08.016
  • Channa R, Sophie R, Khwaja AA, et al. Factors affecting visual outcomes in patients with diabetic macular edema treated with Ranibizumab. Eye. 2014;28:269–278. doi:10.1038/eye.2013.245
  • Sivaprasad S, Crosby-Nwaobi R, Heng LZ, Peto T, Michaelides M, Hykin P. Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT report 5). Br J Ophthalmol. 2013;97(9):1177–1180. doi:10.1136/bjophthalmol-2013-303168
  • Sophie R, Lu N, Campochiaro PA. Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab. Ophthalmology. 2015;122:1395–1401. doi:10.1016/j.ophtha.2015.02.036
  • Raymond NT, Lakshminarayanan V, Reynold D, et al. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community. Diabetes Care. 2009;32(3):410–415. doi:10.2337/dc08-1422
  • Cheng YJ, Kanaya AM, Araneta MRG, et al. Prevalence of diabetes by race and ethnicity in the United States, 2011–2016. JAMA. 2019;322(24):2389–2398. doi:10.1001/jama.2019.19365
  • Pham T, Carpenter JR, Morris T, Sharma M, Petersen I. Ethnic differences in the prevalence of type 2 diabetes diagnosis in the UK: cross-sectional analysis of the health improvement network primary care database. Clin Epidemiol. 2019;11:1081–1088. doi:10.2147/CLEP.S227621
  • Zhang X, Saaddine JB, Chou C, Cotch MF, Cheng YJ, Geiss LS. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA. 2010;304(6):649–656. doi:10.1001/jama.2010.1111
  • Office of National Statistics. 2011 Census Aggregate Data. UK Data Service. June, 2016. doi:10.5257/census/aggregate-2011-1
  • Dinah C, Ghulakhszian A, Sim S, et al. Aflibercept for treatment-naïve diabetic macula oedema in a multi-ethnic population: real-world outcomes from North West London. PLoS One. 2021;16(2):e0246626. doi:10.1371/journal.pone.0246626
  • Korobelnik JF, Do DV, Schmidt-Erfurth U, et al. Intravitreal aflibercept for diabetic macular oedema. Ophthalmology. 2014;121:2247–2254. doi:10.1016/j.ophtha.2014.05.006
  • Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372:1193–1203.
  • Usman M. An overview of our current understanding of diabetic macular ischemia (DMI). Cureus. 2018;10(7):e3064.
  • Tsai ASH, Gan ATL, Ting DSW, et al. Diabetic macular ischemia: correlation of retinal vasculature changes by optical coherence tomography angiography and functional deficit. Retina. 2019. doi:10.1097/IAE.0000000000002721
  • Samara WA, Shahlaee A, Adam MK, et al. Quantification of diabetic macular ischemia using optical coherence tomography angiography and its relationship with visual acuity. Ophthalmology. 2017;124:235–244. doi:10.1016/j.ophtha.2016.10.008
  • Ghazi-Nouri SM, Tranos PG, Rubin GS, Adams ZC, Charteris DG. Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery. Br J Ophthalmol. 2006;90:559–562. doi:10.1136/bjo.2005.085142
  • Wagner-Schuman M, Dubis AM, Nordgren RN, et al. Race- and sex-related differences in retinal thickness and foveal pit morphology. Invest Ophthalmol Vis Sci. 2011;52(1):625–634. doi:10.1167/iovs.10-5886

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.